2 European Advanced Course in Clinical Tuberculosis

2nd European Advanced Course in Clinical Tuberculosis
Venue: Royal Tropical Institute, Amsterdam, the Netherlands
Date: 22-24 September 2014
A 3-day course on Tuberculosis (TB) will be held in Amsterdam on 22-24
September 2014. The course offers you the opportunity to access up-to-date
knowledge in the field of clinical TB. The target group for the course is
clinicians and allied professionals interested in TB.
The course topics include novelties in diagnosis TB and latent TB
infection, medication and treatment among special groups. The course faculty
(Filha, TBNET, University of Tartu and KNCV Tuberculosis Foundation) has a
comprehensive experience in the field of clinical TB. The lectures will be given
by renowned European TB scientists. During the course you will have a
possibility to ask, discuss and network. Participants are invited to forward a
case in advance for the “TB Ward on stage” sessions (more information will
follow after registration).
More info: http://www.kncvtbc.org/european-advanced-course-clinical-tuberculosis
Program Day 1 (22 September 2014)
12.30 – 13.00 Registration & Lunch
13.30 – 13.50 Introduction; Gerard de Vries
1. Tuberculosis situation in the Netherlands & Europe; Tuberculosis
prevention
Chair: Tuula Vasankari
13.50 – 14.10 The history of tuberculosis in The Netherlands; Gerard de Vries, KNCV
Tuberculosis Foundation, The Netherlands
14.10 – 14.30 Epidemiology of tuberculosis in Europe; Marieke van der Werf, ECDC, Sweden
14.30 – 14.50 Latent TB Infection. What is the risk of developing TB? Frank Cobelens, KNCV
Tuberculosis Foundation, The Netherlands
14.50 – 15.10 Preventive chemotherapy; Rob van Hest, KNCV, The Netherlands
15.10 – 15.30 What are the prospects of an “IGRA-skintest”? Morton Ruhwold, Staten Serum
Institute, Copenhagen, Denmark
15.30 – 16.00 Coffee and tea break
16.00 – 16.45 KEY NOTE LECTURE: IGRA’s. What do they tell, and what don’t they tell? Ibrahim
Abubakar, University College of London, England
16.45 – 18.00 “TB Ward on stage”. Case presentation and questions by participants on
diagnostic and therapeutic challenges in latent TB Infection to a panel of experts
Chairs: Christoph Lange, Medical Clinic Research Center Borstel, Germany & Gerard de Vries,
KNCV Tuberculosis Foundation, The Netherlands
18.00 – 20.00 Welcome buffet, Tropenmuseum, Amsterdam (included in the course fee)
++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
Program Day 2 (23 September 2014)
2. (Latent) tuberculosis in the immunocompromised patient
Chair: Graham Bothamley
09.00 – 09.30 What do we now? Overview. Tom Ottenhoff, Leiden University Medical Center,
The Netherlands
09.30 – 09.50 Anti-TNF-alfa medication and tuberculosis; Marleen Bakker, Erasmus Medical
Center, Rotterdam, The Netherlands
09.50 – 10.10 Vitamin D and tuberculosis; Robert Davidson, Northwick Park Hospital, London,
England
10.10 – 10.30 Diabetes Mellitus and tuberculosis; Reinout van Crevel, Radboud University
Medical Center, Nijmegen, The Netherlands
10.30 – 11.00 Coffee and tea break
3. Diagnosis of tuberculosis
Chair: Manfred Danilovits
11.00 – 11.20 What do we know? Overview of TB diagnostics by Tuula Vasankari, Filha,
Helsinki, Finland
11.20 – 11.40 Rapid molecular diagnosis of TB and drug-resistant TB; Jose Dominguez, Institut
d’Investigació en Ciències de la Salut Germans Trias i Pujol, Barcelona, Spain
11.40 – 12.00 Continued challenges in diagnosing drug-resistant TB; Kathleen England, KNCV
Tuberculosis Foundation, The Netherlands
12.00 – 12.20 Biomarkers to measure severity of disease and treatment response; Morton
Ruhwold, Staten Serum Institute, Copenhagen, Denmark
12.20 – 12.40 Appetizer: Can rats detect TB; Christiaan Mulder, APOPO Project, Tanzania
12.40 – 14.00 Lunch
4. Treatment of tuberculosis
Chair: Christoph Lange
14.00 – 14.30 Clinical spectrum and standard treatment of TB; Graham Bothamley, Homerton
University Hospital London, England
14.30 – 14.50 New drugs: bedaquiline and delamanid, Martin Grobusch, Amsterdam Medical
Center, The Netherlands
14.50 – 15.10 Challenges to treat MDR TB, Manfred Danilovits, Tartu University Hospital,
Estonia
15.10 – 15.30 Therapeutic Drug Monitoring: Jan-Willem Alffenaar, hospital pharmacist,
University Medical Centre Groningen, TB Centre Beatrixoord, The Netherlands
15.30 – 16.00 Coffee and tea break
16.00 – 16.45 KEY NOTE LECTURE: Shorter TB regimens. What is in the pipeline? Martin
Boeree, Radboud University Medical Centre, TB Centre Dekkerswald, Nijmegen, The
Netherlands
16.45 – 18.00 “TB Ward on stage”. Case presentation and questions by participants on
diagnostic and therapeutic challenges in TB to a panel of experts
Chairs: Christoph Lange, Medical Clinic Research Center Borstel, Germany & Gerard de Vries,
KNCV Tuberculosis Foundation, The Netherlands
18.00 – 20.00 Dinner (optional). Location and menu will be communicated later (NOT included
in the course fee)
++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
Program Day 3 (24 September 2014)
5. Care of the patient
Chair: Rob van Hest
09.00 – 09.20 The patient perspective; A patient
09.20 – 09.40 Nursing approach; TB Nurse
09.40 – 10.00 People or pathogens? Alistair Story, Find and Treat project London, England
10.00 – 10.10 Video: Modern sanatorium in the Netherlands, TB Centre Beatrixoord
10.10 – 10.30 International perspective of TB control; Kitty van Weezenbeek, KNCV
Tuberculosis Foundation, The Netherlands
10.30 – 11.00 Coffee and tea break
6. TB and TB control in the future
Chair: Gerard de Vries
11.00 – 11.45 KEY NOTE LECTURE: WHO Global Plan for TB beyond 2015 in low-incidence
countries; Mario Raviglione, WHO, Switzerland
11.45 – 12.15 Hot topics on the research agenda; Christoph Lange, Medical Clinic Research
Center Borstel, Germany
12.15 – 12.30 Final discussion; Christophe Lange and Gerard de Vries
12.30 End of course. Lunch will not be provided.

Download Report